Evidence map›Paper›PMID 29115051›Full record

ReviewDevelopmental neurobiology2018

To the end of the line: Axonal mRNA transport and local translation in health and neurodegenerative disease.

Christopher J Costa, Dianna E Willis

Open access · greenAbstract readReview
In one paragraph

Review in Developmental neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Presynaptic Protein Synthesis in Brain Function and Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Axonal mRNA localization and translation: local events with broad roles.Cellular and molecular life sciences : CMLS · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Neurodegeneration and axonal mRNA transportation.American journal of neurodegenerative disease · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Christopher J CostaBurke Medical Research Institute, White Plains, New York, 10605.
Dianna E WillisBurke Medical Research Institute, White Plains, New York, 10605.ORCID 0000-0003-1442-3533
Burke Medical Research Institute · USCornell University · US

Funding

Loss of a cohort of axonal mRNAs as a result of reduced SMN levels.R56NS097568 · NINDS · WINIFRED MASTERSON BURKE MED RES INST · PI WILLIS, DIANNA E. · 2016 to 2016
$475k
NINDS NIH HHS R56 NS097568
6 · The paper itself

Abstract

Axons and growth cones, by their very nature far removed from the cell body, encounter unique environments and require distinct populations of proteins. It seems only natural, then, that they have developed mechanisms to locally synthesize a host of proteins required to perform their specialized functions. Acceptance of this ability has taken decades; however, there is now consensus that axons do indeed have the capacity for local translation, and that this capacity is even retained into adulthood. Accumulating evidence supports the role of locally synthesized proteins in the proper development, maintenance, and function of neurons, and newly emerging studies also suggest that disruption in this process has implications in a number of neurodevelopmental and neurodegenerative diseases. Here, we briefly review the long history of axonal mRNA localization and local translation, and the role that these locally synthesized proteins play in normal neuronal function. Additionally, we highlight the emerging evidence that dysregulation in these processes contributes to a wide range of pathophysiology, including neuropsychiatric disorders, Alzheimer's, and motor neuron diseases such as spinal muscular atrophy and Amyotrophic Lateral Sclerosis. © 2017 Wiley Periodicals, Inc. Develop. Neurobiol 78: 209-220, 2018.

Indexed as

AnimalsAxonal TransportAxonsHumansNeurodegenerative DiseasesRNA, MessengerRNA, Messengeraxonal mRNAlocal translationneurodegenerative diseaseRNA traffickingtransport

Identifiers

PMID29115051
PMCPMC5816713
OpenAlexW2767992943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.